Korean J Hematol 1993; 28(2):

Published online June 30, 1993

© The Korean Society of Hematology

골수검사를 시행한 말초혈구감소증 387례에 대한 고찰

백진영, 홍기숙, 김옥경

이화여자대학교 의과대학 부속병원 임상병리학교실

Observation on 387 Cases of Peripheral Cytopenia Undergone Bone Marrow Examination

Jin Young Baek, Ki Sook Hong, Ok Kyung Kim

Department of Clinical Pathology, College of Medicine, Ewha Womans University, Seoul, Korea

Abstract

Background: The bone marrow examination is being admitted as an essential diagnostic tool for various hematologic and non-hematologic disease, especially the evaluation of a peripheral pancytopenia or bicytopenia. However, in only anemia or bicytopenia, there seems to be an avoiding or reluctant tendency of performing the bone marrow examination due to the prevailing idea of somewhat invasiveness. So we were intended to evaluate the importance of the bone marrow examination as a diagnostic tool in anemia, bicytopenia and pancytopenia.
Methods: We reviewed 387 cases of cytopenia among the total 590 cases which had been performed the bone marrow examinations at the clinical pathology department of
Ewha Womans University Hospital for the past five years(1987-l991). And we classified the cytopenia into four groups, the cases with only anemia (group I), those with both anemia and thrombocytopenia(group II), those with both anemia and leukopenia(group III), and those with pancytopenia(group IV), and analyzed their characteristics.
Results:
1. The group I was 161 cases(41.6%), group II 114 cases(11.4%), group III 44 cases(11.4%), and group IV 68 cases(17.6%).
2. The malignancy rate of the group II(64.0%) or group III(54.5%) was significantly higher than that of the group I(21.1%) or group IV(32.4%)(p<0.05, respectively).
3. The most common cause of malignancy was non-hematopoietic malignancy(6.2%) in group I, AML in group II(24.5%) and III(25.0%), and MDS(19.2%) in group IV.
4. Hypercellular marrow was common in group I and II, and hypocellular marrow was common in group IV.
Conclusion: We suggest that in the condition of bicytopenia such as the anemia and thrombocytopenia or the anemia and leukopenia, the indication of the bone marrow
examination should be mandatory for the possibility of the malignancy.

Keywords Bone marrow, Anemia, Thrombocytopenia, Leukopenia, Malignancy

Article

Korean J Hematol 1993; 28(2): 357-363

Published online June 30, 1993

Copyright © The Korean Society of Hematology.

골수검사를 시행한 말초혈구감소증 387례에 대한 고찰

백진영, 홍기숙, 김옥경

이화여자대학교 의과대학 부속병원 임상병리학교실

Observation on 387 Cases of Peripheral Cytopenia Undergone Bone Marrow Examination

Jin Young Baek, Ki Sook Hong, Ok Kyung Kim

Department of Clinical Pathology, College of Medicine, Ewha Womans University, Seoul, Korea

Abstract

Background: The bone marrow examination is being admitted as an essential diagnostic tool for various hematologic and non-hematologic disease, especially the evaluation of a peripheral pancytopenia or bicytopenia. However, in only anemia or bicytopenia, there seems to be an avoiding or reluctant tendency of performing the bone marrow examination due to the prevailing idea of somewhat invasiveness. So we were intended to evaluate the importance of the bone marrow examination as a diagnostic tool in anemia, bicytopenia and pancytopenia.
Methods: We reviewed 387 cases of cytopenia among the total 590 cases which had been performed the bone marrow examinations at the clinical pathology department of
Ewha Womans University Hospital for the past five years(1987-l991). And we classified the cytopenia into four groups, the cases with only anemia (group I), those with both anemia and thrombocytopenia(group II), those with both anemia and leukopenia(group III), and those with pancytopenia(group IV), and analyzed their characteristics.
Results:
1. The group I was 161 cases(41.6%), group II 114 cases(11.4%), group III 44 cases(11.4%), and group IV 68 cases(17.6%).
2. The malignancy rate of the group II(64.0%) or group III(54.5%) was significantly higher than that of the group I(21.1%) or group IV(32.4%)(p<0.05, respectively).
3. The most common cause of malignancy was non-hematopoietic malignancy(6.2%) in group I, AML in group II(24.5%) and III(25.0%), and MDS(19.2%) in group IV.
4. Hypercellular marrow was common in group I and II, and hypocellular marrow was common in group IV.
Conclusion: We suggest that in the condition of bicytopenia such as the anemia and thrombocytopenia or the anemia and leukopenia, the indication of the bone marrow
examination should be mandatory for the possibility of the malignancy.

Keywords: Bone marrow, Anemia, Thrombocytopenia, Leukopenia, Malignancy

Blood Res
Volume 59 2024

Stats or Metrics

Share this article on

  • line

Related articles in BR

Blood Research

pISSN 2287-979X
eISSN 2288-0011
qr-code Download